The ReVERSE Program is a monthly $75 subscription to complement your ReCODE Report (ReVERSE subscribers have the option to purchase blood and genome tests at a discounted rate of $1,099 or have a trained practitioner order the tests). The program includes generation of unlimited ReCODE Report, full complimentary access to our trained ReCODE practitioner database, exclusive ReCODE content, Monthly Town Halls with Dr. Bredesen, and unlimited access to AHNP’s proprietary ReCODE Mobile Application (Coming 2019).
The ReVERSE Program is derived from the principles of the ReCODE Protocol, and provides specifically catered support to compliment your ReCODE Report. The ReVERSE Program is designed for individuals who require more resources to combat cognitive decline. Utilizing AHNP’s ReCODE engine and Dr. Bredesen’s 30+ years of research, we can provide better and more precise outcomes of care, paired with AHNP’s network of ReCODE Certified team of physicians, specialists, health coaches, and nutritionists.
All ReCODE and Bredesen Protocol assessments and initial treatment suggestions must start with a ReCODE Report, which is included with the ReVERSE Program. AHNP highly recommends consulting with a ReCODE Certified practitioner before starting the protocol.
The ReCODE subscription requires a one year commitment. Baseline labs cost $1,099 or labs can be ordered separately by a trained practitioner. For further questions, contact us at firstname.lastname@example.org.
The program is designed to accommodate and support your ReCODE treatment process, which may take 3 months to a year to show initial reversal or improvement. Treatment must continue to maintain effective reversal of cognitive decline and continued improvement.
Alzheimer’s disease is one of the most significant health care problems nationally and globally. Recently, the first description of the reversal of cognitive decline in patients with early Alzheimer’s disease or its precursors, MCI (mild cognitive impairment) and SCI (subjective cognitive impairment), was published. The therapeutic approach used was programmatic and personalized rather than monotherapeutic and invariant, and was dubbed metabolic enhancement for neuro degeneration (MEND). Patients who had to discontinue work were able to return to work, and those struggling at work were able to improve their performance.
The ReCODE subscription requires a one year commitment. Baseline labs cost $1,099 or labs can be ordered separately by a trained practitioner. For further questions, contact us at email@example.com. If you are located outside of the US, please contact us for more details.
Identify the subtypes and source of your cognitive decline.
ReCODE is the first to report the reversal of cognitive decline in patients with early Alzheimer's disease.
Unlimited access to a directory of ReCODE trained practitioners, coaches, and nutritionists.
Receive catered content and support to compliment your treatment plan.
Direct interface with a ReCODE trained physician, nutritionist, or health coach.